Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. A double-blind randomized clinical study. 1997

M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
Department of Anesthesiology, Medisch Spectrum Twente Enschede, The Netherlands.

OBJECTIVE The purpose of this study was to compare the effectiveness of three local anesthetic agents for intravenous regional anesthesia in the upper limb. Side effects and plasma concentrations of the drugs in the doses administered for IVRA were also studied. METHODS Thirty patients in ASA groups I and II received intravenous regional anesthesia for surgery of the upper limb. In a double-blind prospective study, they were randomly allocated to receive one of three local anesthetics: articaine, lidocaine, or prilocaine. Patients received 40 mL of a 0.5% solution of the local anesthetic. The onset time of sensory block was assessed by pinprick and the extent of motor block was was scored as 0-3. Plasma concentrations of local anesthetics were determined in all patients from serial arterial blood samples drawn at predetermined times before and after tourniquet release. RESULTS The onset time of sensory block was significantly shorter (2.5 minutes) in the articaine group than in the lidocaine group (11.1 minutes) or the prilocaine group (10.9 minutes) (Scheffe, P < .05). Development of motor block was equal in all three groups (score 2). Estimation of plasma concentrations by high performance liquid chromatography showed that the peak level in all 30 patients was reached immediately after release of the tourniquet; plasma concentrations thereafter gradually declined. Maximum concentrations of articaine, lidocaine, and prilocaine were, 1.85, 8.5, and 4.4 micrograms/mL, respectively. No signs of local anesthetic toxicity of the cardiovascular or central nervous systems were seen. CONCLUSIONS Articaine had the fastest onset of sensory block and the lowest peak plasma concentration of the three local anesthetics when used for intravenous regional anesthesia.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011318 Prilocaine A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry. Propitocaine,Citanest,Citanest Octapressin,Prilocaine Hydrochloride,Xylonest
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002355 Carticaine A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE. Articaine,Articain,Carticain,Carticaine Hydrochloride,Hoe-045,Hoe-40045,Ultracaine,Hoe 045,Hoe 40045,Hoe045,Hoe40045,Hydrochloride, Carticaine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
July 1992, Anaesthesia,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
December 2002, Der Anaesthesist,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
January 1999, Regional anesthesia and pain medicine,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
August 1995, Acta anaesthesiologica Scandinavica,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
April 2006, Journal of endodontics,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
June 2004, Anesthesia and analgesia,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
September 1988, Anesthesiology,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
January 1990, Regional anesthesia,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
December 2003, Croatian medical journal,
M A Simon, and M J Gielen, and N Alberink, and T B Vree, and J van Egmond
October 1985, Regional-Anaesthesie,
Copied contents to your clipboard!